Matthew W. Foehr - 02 May 2022 Form 4 Insider Report for Viking Therapeutics, Inc. (VKTX)

Role
Director
Signature
/s/ Michael Morneau, as Attorney-in-Fact
Issuer symbol
VKTX
Transactions as of
02 May 2022
Net transactions value
+$111,195
Form type
4
Filing time
03 May 2022, 16:12:35 UTC
Previous filing
16 Feb 2022
Next filing
09 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VKTX Common Stock, par value $0.00001 per share Purchase $111,195 +45,000 +68% $2.47 111,250 02 May 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.